Literature DB >> 31331134

Clinico-hematological Profile of Hb E-β Thalassemia-Prospective Analysis in a tertiary Care Centre.

Krushna Pani1, Seema Sharma2, Manjula Murari2, Mahima Yadav3, Shubha Phadke4, Sarita Agarwal4.   

Abstract

INTRODUCTION: Hemoglobin E beta-thalassemia is one of the leading forms of severe thalassemia world wide. This disorder is more commonly found in South East Asia including north eastern states of India. Patients suffering from this disorder show marked clinical heterogeneity.
MATERIALS AND METHODS: Referred cases of hemoglobin disorders from north India were evaluated prospectively. Details of clinical history and haematological findings including HPLC as well as mutation analysis were obtained.
RESULTS: Twenty cases of E beta-thalassemia with widely variable clinical profile were included. The hematological parameters were also extremely variable with a wide range of hemoglobin (1.8-9.9 g/dl). Applying a severity scoring system all patients were classified the patients into mild (n=6), moderate (n=7) and severe (n=7) subclasses. We also correlated red cell Indies with HB E and HB F as well as age of onset of symptoms with HB E and HB F. IVS1-5(G-C) was found to be the most common thalassemia mutation associated with Hemoglobin E beta-thalassemia.
CONCLUSION: Extremely variable clinical and haematological findings were observed in Hemoglobin E beta-thalassemia patients. These findings are comparable to other Indian studies. Appropriate knowledge of the clinical variability and unpredictable natural history can help better management of this group of patients. © Journal of the Association of Physicians of India 2011.

Entities:  

Mesh:

Year:  2018        PMID: 31331134

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  3 in total

1.  A Case of Anaemia With High-Grade Splenomegaly.

Authors:  Ranjan K Singh
Journal:  Cureus       Date:  2022-05-11

2.  Phenotypic Diversity and Clinico-Hematological Profile of Hb E-Beta Thalassemic Children.

Authors:  Aditi Baruah; Mrinal Kumar Baruah
Journal:  Indian J Hematol Blood Transfus       Date:  2019-07-04       Impact factor: 0.900

Review 3.  Activation of STAT and SMAD Signaling Induces Hepcidin Re-Expression as a Therapeutic Target for β-Thalassemia Patients.

Authors:  Hanan Kamel M Saad; Alawiyah Awang Abd Rahman; Azly Sumanty Ab Ghani; Wan Rohani Wan Taib; Imilia Ismail; Muhammad Farid Johan; Abdullah Saleh Al-Wajeeh; Hamid Ali Nagi Al-Jamal
Journal:  Biomedicines       Date:  2022-01-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.